Objectives: Oleanolic acid, a minor element of ginsenosides, and its derivatives have been shown to have cytotoxicity against some tumor cells. The impact of cytotoxic effect of oleanolic acid 3-acetate on ovarian cancer SKOV3 cells and endometrial cancer HEC-1A cells were examined both in vivo and in vitro to explore the underlying mechanisms. Methods: Cytotoxic effects of oleanolic acid 3-acetate were assessed by cell viability, phosphatidylserine exposure on the cell surface, mitochondrial release of cytochrome C, nuclear translocation of apoptosisinducing factor, depolarization of mitochondrial transmembrane potential (DJ m ), and generation of reactive oxygen species (ROS). In vivo inhibition of tumor growth was also assessed with xenografts in immunocompromised mice. Results: Oleanolic acid 3-acetate exhibited potent cytotoxicity toward SKOV3 and HEC-1A cells by decreasing cell viability in a concentration-dependent manner. Importantly, oleanolic acid 3-acetate effectively suppressed the growth of SKOV3 cell tumor xenografts in immunocompromised mice.
Introduction
Oleanane triterpenoids, synthesized in many plants including Panax ginseng Meyer and widely used in traditional oriental medicine, have been shown to be clinically effective antiinflammatory and antitumorigenic agents [1] . To improve their anticancer potency, some chemical modifications have been introduced, and some are met with positive outcomes [2] . These synthetic oleanane triterpenoids (SOTs) primarily come into play in relation to inflammation, oxidation, proliferation, and apoptosis. Despite much effort to elucidate the structureefunction relationship of SOTs for the chemoprevention and chemotherapy of cancers, the active moieties that could confer anticancer therapeutics to SOT are currently not known, nor is the molecular target(s) of SOT in cancer prevention. However, SOT and its derivatives offer a very promising anticancer intervention because of their potential to regulate a rather broad range of dysfunctional pathways that are frequently encountered in many types of cancer, highlighting a broad relevance for the cancer control.
Ovarian cancer is one of the high mortality-inflicted gynecological malignancies worldwide [3] . The high mortality associated with ovarian cancer is largely attributable to the sporadic emergence of symptoms in an early stage of disease progression and a paucity of effective screening methods. Not surprisingly, most women are diagnosed in such an advanced stage that the 5-year survival rates are nowhere near as high as 50% while diagnosis made in the early stage being confined to the ovaries leads to significantly increased 5-year survival rate of about 90%. This assessment necessitates an effective early screening/detection method to lower the disease-associated mortality [4] . On the other hand, the nature of cancer genome, e.g., progressive accumulation of multiple mutations in tumor as it progresses, might confer upon ovarian cancer the lack of specific early symptoms and some difficulties met in early diagnosis. Indeed, mutations of more than 100 genes were described in human breast and colorectal cancers [5] , and the same might be true in other types of cancer. The present notion is that tumor cells might contain thousands of mutations resulting from stochastic and environmental processes. Consequently, no rate-limiting steps or pathways could be uniquely targeted to deter the progression of tumor [6] . By extrapolation, these findings suggest that the combination chemotherapy is of better use than any single drug-based dosing. Albeit different extents, binding to many individual signaling molecules renders SOT a better chemotherapeutic agent providing higher potential to regulate a variety of defective pathways in premalignant or malignant cells than an agent that may target a specific step in a signaling pathway [7] .
Apoptosis is considered a precise self-regulating death-leading process, which plays a central role in controlling development and homeostasis of multicellular organisms. Therefore, its malfunction has been closely associated with various diseases, including cancers and cell-degenerative disorders [8] . The two major apoptotic routes have been recognized: the mitochondria-mediated pathway and the cell surface death receptoremediated pathway. Of the two, binding of a death receptor ligand to the cell surface death receptor leads to activation of caspase-8 and downstream caspases [9] . In the mitochondrial pathways, internal death cues are finally converted to triggering the depolarization of mitochondrial membrane potential (DJ m ), which is a prerequisite to the mitochondrial cytochrome c release into the cytosol. Released cytochrome c binds to the apoptotic protease activation factor Apaf-1, subsequently leading to caspase-9 activation. Activated caspase-9 further activates many downstream caspases, which collectively leads to apoptosis [10] . In addition, many studies have reported that some anticancer drugs could trigger cells to produce reactive oxygen species (ROS), which in turn takes part in the mitochondrionmediated apoptosis by dissipating DJ m [11] while others induce apoptosis through the mitochondrial pathway characterized by ROS independence [12e14] .
In the present study, we sought to investigate effects of oleanolic acid 3-acetate, a newly synthesized oleanane-based derivative, on the cytotoxicity against human ovarian cancer SKOV3 cells and endometrial cancer HEC-1A cells, and explore its underlying molecular mechanism whereby cancer cells are apoptotically controlled.
Materials and methods

Chemicals
Followings are the lists of materials used and their manufacturers: (a) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT), dichloro-dihydro-fluorescein diacetate (DCFH-DA), and DiOC 6 were purchased from Sigma-Aldrich (St. Louis, MO); (b) Annexin V fluorecein isothiocyanate (FITC) Apoptosis Detection Kit I was from BD Pharmingen (San Diego, CA); (c) Rabbit polyclonal anti-human antibodies against cleaved caspase-3, caspase-7, caspase-8, poly(ADP-ribose) polymerase (PARP), cleaved PARP, and Bcl-2 were from Cell Signaling Technology (Danvers, MA); (d) Rabbit polyclonal anti-human antibodies against cytochrome c, apoptosis-inducing factor (AIF), HSP60, and mouse monoclonal anti-human b-actin were from Santa Cruz Biotech (Santa Cruz, CA); (e) horse radish peroxidaseeconjugated antirabbit IgG and FITC-conjugated anti-rabbit IgG were obtained from Invitrogen (Grand Island, NY); (f) Roswell Park Memorial Institute (RPMI) 1640 medium, fetal bovine serum (FBS), and other tissue culture supplies were from Gibco-BRL (Grand Island, NY); (g) Mitochondria Isolation Kit for Cultured Cells was from Thermo Scientific (Rockport, IL); (h) Oleanolic acid, oleanolic acid acetate, and oleanolic acid methyl ester were purchased from SigmaAldrich, BOC Sciences (Shirley, NY), Extrasynthese (Genay, France), respectively. Oleanolic acetate methyl ester was derived from oleanolic acid methyl ester in the presence of pyridine by reacting with acetic anhydride overnight at room temperature. 
Cell culture
SKOV3 cell, a human ovarian cancer cell line, and HEC-1A cell, a human endometrial carcinoma cell line, were obtained from the American Type Culture Collection (Manassas, VA) and maintained according to the manufacturer's instruction at 37 C in RPMI 1640 medium supplemented with 100 U/mL of penicillin, 100 mg/mL of streptomycin, and 10% FBS in a humidified incubator in the presence of 5% CO 2 . Human endometrial tissues at the proliferative phase were isolated by surgical curettages of the hysterectomized uteri of patients at the Ajou University Hospital (Suwon, South Korea) with no apparent diagnosis of endometrial diseases. Informed consent was obtained from a patient before the surgery following the Ajou University Institutional Review Board preapproval (Suwon, South Korea). From the pooled endometrial tissues, the stromal celleenriched fractions were isolated and maintained as described previously [15] .
Oleanolic acid 3-acetate treatment and determination of cytotoxicity
Cells in a logarithmic growth phase were harvested and seeded in a 96-well plate at a density of 5 Â 10 3 cells/mL (SKOV3 cells) and
The viability of each cell was examined by MTT assay as described previously [16] . All the experiments were repeated three to five times, and the average is presented. Cell survival was calculated according to the following formula: survival (%) ¼ experimental absorbance/control absorbance Â 100.
Flow cytometric assessment of phosphatidylserine exposure on the cell surface
The extent of phosphatidylserine exposure on the cell surface membrane was one of the hallmarks to quantify early apoptosis by flow cytometry with FITCeAnnexin V binding as described previously [17] . In short, about 6 Â 10 5 cells were seeded in a 25-cm 
Assessment of mitochondrial release of AIF
About 5 Â 10 4 cells were seeded on a coverslip in a 24-well plate in RPMI 1640 medium. Twenty four hrs after seeding, oleanolic acid 3-acetate was added at the final concentrations of 0e40 mM for 24 h. The cells on the coverslip were washed once with ice-cold PBS, fixed in 1 mL of 4% paraformaldehyde for 20 min, washed once with ice-cold PBS containing 5% bovine serum albumin to prevent nonspecific bindings, and incubated for 1 h with anti-AIF antibody at a 1:100 dilution. After washing with ice-cold PBS, FITCconjugated secondary antibody at 1:100 dilution was added and incubated for 1 h followed by replacing the antibody solution with a staining solution containing PI at 100 nM and further incubated for 5 min. After three washes with ice-cold PBS, the coverslip was mounted onto a glass slide using the antifade mounting reagent. The slides were viewed under a confocal laser-scanning microscope (TCS STED; Leica Microsystems, Bannockburn, IL).
Measurement of mitochondrial transmembrane potential
DJ m was measured by flow cytometry (FACSCaliber) after staining with fluorescent mitochondrial tracking dye DiOC 6 . After being exposed to oleanolic acid 3-acetate for 24 h, 1 Â 10 6 cells were harvested, centrifuged at 1,000 rpm in a table-top centrifuge for 5 min, washed with ice-cold PBS once, incubated with 40 nM DiOC 6 at 37 C for 15 min in the dark, and analyzed by a flow cytometer (FACSCaliber) with excitation at 488 nm and emission at 510 nm after washing with PBS. The data obtained from the flow cytometry were further analyzed by using the CellQuest software and expressed as mean fluorescence intensity.
Measurement of ROS production
DCFH-DA is a membrane-permeable dye that specifically detects ROS. About 1 Â 10 6 cells were exposed to either 1e40 mM oleanolic acid 3-acetate or 1 mM H 2 O 2 for 24 h. Cells were harvested, washed once with ice-cold PBS, and incubated with DCFH-DA at a final concentration of 100 mM at 37 C for 15 min in the dark.
After a wash and resuspending in 1 mL of PBS, ROS generation was assessed by a flow cytometer (FACSCaliber) with excitation and emission at 488 nm and 530 nm, respectively. The DCF fluorescence data were further customized by using the CellQuest software and expressed as mean fluorescence intensity.
Immunoblotting
After being exposed to oleanolic acid 3-acetate for 24 h, cells were harvested by centrifugation, solubilized in the lysis buffer that constitutes 2% Triton X-100 and 0.1% sodium dodecyl sulfate (SDS) dissolved in 150 NaCl, 25 Tris-HCl, pH 7.4 in mM, supplemented with a protease/phosphatase inhibitor cocktail. The total cell lysates were recovered by centrifugation at 15,000Âg for 30 min. About 30e50 mg of protein lysates was loaded into a well of the SDSepolyacrylamide gel, subjected to separation by electrophoresis, and transferred onto nitrocellulose membranes. The membranes were first incubated in the blocking solution containing 5% skim milk and 0.1% Tween-20 in PBS at room temperature for 1 h and then were further incubated with appropriate primary antibodies diluted in the blocking solution overnight at 4 C. Finally, the membrane blots were incubated with appropriate horse radish peroxidaseeconjugated secondary antibodies at 1:3,000 dilution at room temperature for 1 h. Visualization was made by enhanced chemiluminescence using the Western blotting luminol reagent and a luminescent image analyzer (Las-1000; Fuji Film, Tokyo, Japan). All primary antibodies were diluted at 1:1,000 except the mouse monoclonal anti b-actin antibody (1:4,000). For a quantitative comparison, the intensity of immunoblots was quantified using Multigauge V3.0 software (Fuji Film).
Mitochondrial fractionation
Mitochondria-enriched fractions were isolated from cells using the Mitochondria Isolation Kit for Cultured Cells following the manufacturer's protocol. Briefly, 2 Â 10 7 exponentially growing cells were cultured, treated with oleanolic acid 3-acetate for 24 h, and then harvested by centrifugation. The mitochondrial and cytosolic fractions were prepared from the cells using the reagentbased and Dounce homogenization methods of the kit.
Ovarian cancer xenografts
Female athymic mice, BALB/c nu/nu, 6-to 8-weeks old, were obtained from Orient Bio (Sungnam, South Korea) and housed in sterile cages at controlled temperature (23 AE 2 C), lighting (12 h), and humidity (60 AE 5%). Food and water were available ad libitum. All animal experimental procedures were prereviewed and approved by the Institutional Animal Research Ethics Committee at Ajou University, Suwon, South Korea. Transplantable SKOV3 cells were cultured, harvested, and suspended at a concentration of 5 Â 10 7 cells/mL in PBS. The athymic mice were inoculated subcutaneously (s.c.) into the left flank with 5 Â 10 6 SKOV3 cells in 100 mL of PBS as described elsewhere [18] . When the external diameter of tumors reached approximately 0.5 cm, the mice were randomly divided into following five groups: Group 1, treated with 0.1% dimethylsulfoxide (DMSO) in saline; Group 2, treated with cisplatin; and Groups 3, 4 and 5, treated with oleanolic acid 3-acetate at different doses. Administration of a dose comprises: Groups 1 and 2 mice were randomly treated intraperitoneally (i.p.) with 50 mL of 0.1% DMSO and cisplatin at 5 mg/kg dosage once a week for 3 weeks, respectively. Groups 3, 4, and 5 mice were treated i.p. with 50 mL of oleanolic acid 3-acetate at 10, 20, and 40 mg/kg, respectively, every day for 3 weeks according to the previous study [19] . The weights of animals were measured every 3 days. When receiving the desired drug dosage, each animal was tagged in the ear and monitored individually throughout the experiment. Starting on the first day of the drug treatment, the volume of the tumor xenografts was assessed every 3 days according to the following formula: with two perpendicular diameters A and B, the tumor volume (V) was estimated as V ¼
. The mice were killed by cervical dislocation when the mean tumor weight was more than 1 g compared to controls. Tumors were excised from the mice, and their weight was measured.
The ratio of inhibition (IR) was calculated according to the following formula:
IR ¼ 1 À tumor weight of experimental animal tumor weight of control animal Â 100ð%Þ
Statistical analysis
The statistical analysis was performed by Student t test or oneway analysis of variance with IBM SPSS Statistics 20 (IBM-Korea, Seoul, South Korea). A p value < 0.05 was set to be indicative of significant difference.
Results
Oleanolic acid 3-acetate inhibits proliferation of SKOV3 and HEC-1A cells
We evaluated the cytotoxic effects of oleanolic acid 3-acetate on two tumor cell lines SKOV3 cells and HEC-1A cells. The cells were treated with oleanolic acid 3-acetate at the final concentrations ranging from 0 to 40 mM for 24 h and subjected to MTT assay to evaluate cell viability. Oleanolic acid 3-acetate exhibited anticellular proliferation of SKOV3 and HEC-1A cells in a concentrationdependent manner (Fig. 1B) , suggesting that oleanolic acid 3-acetate has a cytotoxicity toward SKOV3 and HEC-1A cells with the half maximal inhibitory concentrations estimated to be 8.3 and 0.8 mM, respectively. In contrast, human endometrial stromal cells, which were assumed to a normal counterpart of HEC-1A cells, showed little, if any, cytotoxicity caused by oleanolic acid 3-acetate (w95% cell survival at 10 mM).
Oleanolic acid 3-acetate induces apoptotic cell death
An assessment of apoptosis was made by measuring the exposure of phosphatidylserine on the cell surface. SKOV3 and HEC-1A cells were exposed to varying concentrations (0e20 mM) of oleanolic acid 3-acetate for 24 h and then subjected to flow cytometric analysis after annexin V and PI double staining. The early apoptotic cell population (annexin V þ /PI À ) in SKOV3 and HEC-1A cells was 3.9 AE 0.5% and 4.9 AE 0.5% in the control (0 mM), 11.5 AE 2.7% and 11.6 AE 2.6% at 5 mM, 22.4 AE 2.4% and 13.8 AE 2.8% at 10 mM, and 26.1 AE 3.8% and 35.9 AE 3.9% at 20 mM oleanolic acid 3-acetate ( Fig. 2A and B), indicating that the percentage of apoptotic cell population increases with oleanolic acid 3-acetate concentration.
Oleanolic acid 3-acetate induces AIF translocation from the mitochondria to the nucleus
AIF is a mitochondrial flavoprotein that is released from the mitochondria in response to intrinsic death stimuli, subsequently translocated into the nucleus before the nuclear DNA condensation ensues [20] . We then tested whether oleanolic acid 3-acetate induced apoptotic cell death through the AIF-mediated pathway. Translocation of AIF into the nucleus was visualized by immunostaining for AIF and PI staining for the nucleus. Our results clearly showed that AIF was released into the cytosol and then translocated into the nucleus after oleanolic acid 3-acetate treatment in a concentration-dependent manner (Fig. 3A) , suggesting that AIF release and translocation are involved in the oleanolic acid 3-acetateeinduced apoptotic cell death of SKOV3 cells.
Oleanolic acid 3-acetate induces the loss of mitochondrial transmembrane potential
The loss of DJ m is regarded as one of the hallmarks in apoptotic cell death, and as such, DiOC 6 is frequently used as a mitochondrion-specific and voltage-dependent dye for DJ m in living cells. To test for the oleanolic acid 3-acetateemediated apoptotic pathway, we measured the effect of oleanolic acid 3- (Fig. 3B) , suggesting that oleanolic acid 3-acetate induces apoptotic cell death involving, at least, mitochondrial dysfunction.
Oleanolic acid 3-acetate reduces intracellular ROS production
We then revisited the question of whether ROS production was increased upon oleanolic acid 3-acetate treatment because ROS is regarded as a potential factor related to the mitochondriondependent cell injury. Cellular ROS level was determined by flow cytometry using the ROS-sensitive fluorescent probe DCFH-DA.
After being exposed to 0e40 mM of oleanolic acid 3-acetate for 24 h, the cellular levels of ROS were 84.3 AE 8.0%, 72.1 AE 11.0%, 65.4 AE 8.1%, 57.9 AE 10.6%, and 54.6 AE 13.3% as relative to control (0 mM) in SKOV3 cells and 80.9 AE 2.9%, 65.8 AE 3.7%, 57.4 AE 4.9%, 53.6 AE 6.9%, and 51.1 AE 2.0% in HEC-1A cells, respectively (Fig. 3C ). Note that the ROS level was increased when cells were exposed to 1 mM H 2 O 2 with 199.8 AE 30.0% and 217.9 AE 19.4% relative to control in SKOV3 and HEC-1A cells, respectively (data not shown). These findings strongly suggest that oleanolic acid 3-acetate induces apoptotic cell death in SKOV3 and HEC-1A cells but in an ROSindependent manner.
Oleanolic acid 3-acetate activates a mitochondrial apoptotic pathway and its downstream signaling components
To explore the underlying apoptotic pathway associated with the response of cells to oleanolic acid 3-acetate, we examined the activation states of signaling components downstream of the mitochondrial apoptotic pathway. Oleanolic acid 3-acetate treatment led to the activation of several apoptotic signaling molecules including caspase-3, caspase-7, caspase-8 and their substrate PARP in a concentration-dependent manner while a dramatic reduction in Bcl-2 level, a major antiapoptotic regulator, was manifested (Fig. 4A) . The mitochondrial apoptotic pathway is characterized by cytochrome c release from the mitochondria into the cytoplasm concomitant with the loss of DJ m [21] . To differentiate mitochondrial cytochrome c from cytoplasmic cytochrome c, immunoblotting was performed with cytoplasmic and mitochondrial soluble fraction obtained from HEC-1A cells after oleanolic acid 3-acetate treatment. The concentration-dependent accumulation of cytochrome c in the cytosol and corresponding disappearance from the mitochondria were observed along with AIF, implying cytochrome c and AIF release from the mitochondria to the cytoplasm is accelerated upon oleanolic acid 3-acetate treatment (Fig. 4BeD) . Taken together, the data clearly demonstrate that oleanolic acid 3-acetate induces apoptotic cell death in an ROS-independent but mitochondria-mediated pathway.
Oleanolic acid 3-acetate inhibits growth of SKOV3 cell xenografts in nude mice
To further validate oleanolic acid 3-acetate antitumor activity in a cell culture model, we then sought to investigate its antitumor effects in a xenograft mouse model of ovarian cancer. First, we established SKOV3 cell xenografts in nude mice by injecting SKOV3 cells into the frank. After 3 weeks of growth, the external tumor size became visible with an average diameter of 0.5 cm. Then, the mice were randomly divided and subjected to a daily i.p. injection of oleanolic acid 3-acetate for the next 19 days. The first group of mice received a vehicle solution (0.1% DMSO diluted in saline), and the second group of mice received cisplatin at a dose of 5 mg/kg body weight. The last 3 groups of mice received oleanolic acid 3-acetate at a dose of 10, 20, and 40 mg/kg body weight, respectively. The tumor volume was measured every 3 days, and the mice were sacrificed at the end of the experiment to excise tumors, and their weights were measured. The tumor volume was steadily increased by 3.5 folds from approximately 1.0 cm 3 at day 1 to 3.5 cm 3 at day 19 without any oleanolic acid 3-acetate treatment. The daily treatment of oleanolic acid 3-acetate suppressed the tumor growth in a dosage-dependent manner, and at the highest dosage used (40 mg/kg), the tumor growth was suppressed by as much as 23% ( Fig. 5A and B) . The tumor weight also revealed the antitumoral effect of oleanolic acid 3-acetate such that the tumor weight was 2.19 AE 0.88 g in the vehicle control, whereas those were 1.48 AE 0.46, 1.35 AE 0.39, and 1.18 AE 0.38 g at a dose of 10, 20, and 40 mg/kg, respectively (p < 0.05) ( Table 1) . Accordingly, the corresponding tumor growth inhibition ratios were 32.50, 38.47, and 46.02%, respectively. Importantly, oleanolic acid 3-acetate did not cause any death and weight loss in the concentration range used (Table 1) , suggesting that oleanolic acid 3-acetate effectively inhibits the growth of SKOV3 cells in vivo but has little, if any, toxicity toward the normal tissues.
Discussion
Oleanane triterpenoids are found in numerous plants and plant extracts including Panax ginseng Meyer. Owing to easy preparation and enriched biological activities, oleanane triterpenoid framework is yet to provide an interesting template for combinatorial and medicinal chemistry. Supporting this view are a certain number of oleanane triterpenoids that exhibit promising antiproliferative activities. In line with this view, we synthesized a novel oleanane triterpenoid, namely, oleanolic acid 3-acetate and explored its anticancer activity against ovarian cancer and endometrial cancer, two most frequently encountered gynecological cancers, with a hope to evaluate its anticancer efficacy and to elucidate underlying mechanisms for its anticancer activities.
It is interesting to note that higher mammals have evolved complex death pathways, many of which converge on apoptotic programs via the mitochondria as a key regulatory component [22] . Our data clearly supported the view that oleanolic acid 3-acetate has an anticancer activity by stimulating apoptotic cell death mainly mediated by mitochondrial dysfunction. Concentrationdependent abolition of DJ m , release of AIF and cytochrome c, and decrease in Bcl-2 all support the notion that oleanolic acid 3-acetate exerts its anticancer activity via a mitochondria-mediated pathway.
There are some issues, however, that need to be addressed pertaining to proper interpretation of the present study. Are the doses that we used a biological active dose rather than a maximum tolerated dose? In this study, the concentrations were 0e40 mM of oleanolic acid 3-acetate. Within these concentration ranges, oleanolic acid 3-acetate causes a concentration-dependent cytotoxicity, implying that the concentration tested may not be physiologically saturated or maximally tolerated in cancer cells. It is also well established that many good drugs have high affinities toward the target molecules in nM concentration range, especially when its target is a single protein [23] . We measured the cytotoxicity of oleanolic acid 3-actate as revealed by the MTT assay. The cytotoxicity as assessed by the MTT assay may reflect a massive structural or functional change subsequently to cumulative downstream events of apoptotic or necrotic signal cascades; in other words, accumulation of many subtle early events may lead to massive structural or functional changes, such as mitochondrial depolarization and DNA fragmentation before leading to cell death. Thus, at relatively high concentrations, either 20 or 40 mM, nonspecific actions exerted by oleanolic acid 3-acetate could not be carefully differentiated from genuine apoptotic events by the MTT assay. This possibility is more likely to explain why high concentrations of oleanolic acid 3-acetate cause cytotoxicity toward normal epithelial cells.
Generally, the generation of ROS induced by cancer chemotherapeutics triggers the mitochondrial pathways [11, 24, 25] . In contrast, some reports also point out apoptosis via mitochondrial pathway but independent of ROS generation [12, 13] . Intriguingly, oleanolic acid 3-acetate decreased the cellular ROS level at the concentrations used (0e40 mM) both in SKOV3 cells and HEC-1A cells. Our results strongly suggest that oleanolic acid 3-acetate triggers apoptotic cell death via a novel mitochondrion-dependent but ROS-independent pathway. Further studies are needed to clarify this seemingly conflicting novel pathway.
In conclusion, oleanolic acid 3-acetate effectively induced apoptotic cell death in SKOV3 cells and HEC-1A cells both in vitro and in vivo. Its underlying mechanism is mostly likely to be linked to an ROS-independent mitochondrial dysfunction. Therefore, oleanolic acid 3-acetate may be a promising new compound benefiting the cancer chemotherapy.
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